National Health Investors Inc (NYSE:NHI) has been assigned an average recommendation of “Hold” from the six research firms that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating and four have given a hold rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $77.00.
Separately, Zacks Investment Research raised National Health Investors from a “sell” rating to a “hold” rating in a research note on Tuesday, September 24th.
In other National Health Investors news, CIO Kevin Carlton Pascoe sold 900 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $82.46, for a total value of $74,214.00. Following the completion of the sale, the executive now owns 27,826 shares of the company’s stock, valued at $2,294,531.96. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 5.11% of the stock is owned by corporate insiders.
Shares of NYSE NHI traded down $0.48 during midday trading on Thursday, hitting $81.91. 168,507 shares of the company’s stock were exchanged, compared to its average volume of 201,960. The company has a market cap of $3.58 billion, a price-to-earnings ratio of 14.95, a PEG ratio of 3.79 and a beta of 0.33. The business’s fifty day moving average price is $82.78 and its two-hundred day moving average price is $79.50. The company has a current ratio of 14.42, a quick ratio of 14.42 and a debt-to-equity ratio of 1.04. National Health Investors has a 12-month low of $70.54 and a 12-month high of $84.75.
National Health Investors (NYSE:NHI) last issued its earnings results on Thursday, August 8th. The real estate investment trust reported $0.92 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.37 by ($0.45). The firm had revenue of $78.10 million during the quarter, compared to analysts’ expectations of $77.64 million. National Health Investors had a return on equity of 11.00% and a net margin of 50.71%. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.38 EPS. Equities analysts expect that National Health Investors will post 5.49 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Monday, September 30th will be paid a $1.05 dividend. This represents a $4.20 annualized dividend and a yield of 5.13%. The ex-dividend date is Friday, September 27th. National Health Investors’s dividend payout ratio is currently 76.64%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Recommended Story: Are all No-Load Funds Equal?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.